Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 13, 2014 9:41am EST

OPKO Announces Successful Confirmation of 4Kscore™ Algorithm in the United States

Feb 06, 2014 11:52am EST

OPKO Health Announces the Appointment of Greg Stanley as Vice President of Sales and Marketing for its Global Diagnostics Business Unit

Feb 03, 2014 9:16am EST

Neovasc, an OPKO Investee, Reports Successful First Human Implant of Tiara™ Transcatheter Mitral Valve

Jan 09, 2014 11:29am EST

OPKO Health to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Jan 08, 2014 9:36am EST

OPKO Health Completes Acquisition of Laboratorio Arama de Uruguay Limitada

Dec 19, 2013 10:20am EST

OPKO Records Highly Successful Exit of Investment in Sorrento Therapeutics

Dec 19, 2013 8:30am EST

OPKO Completes Patient Recruitment in Second Phase 3 Trial of RayaldyTM

Dec 16, 2013 8:30am EST

OPKO Announces Investor Conference Call Details

Dec 16, 2013 8:30am EST

OPKO Health to Expand Latin American Presence with Acquisition of Uruguayan Pharmaceutical Company

Dec 13, 2013 1:12pm EST

OPKO To Hold Investor Conference

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap